Cocaine-mediated repression of the histone methyltransferase (HMT) G9a has recently been implicated in transcriptional, morphological and behavioral responses to chronic cocaine administration. Here, using a ribosomal affinity purification approach, we found that G9a repression by cocaine occurred in both Drd1-expressing (striatonigral) and Drd2-expressing (striatopallidal) medium spiny neurons. Conditional knockout and overexpression of G9a within these distinct cell types, however, revealed divergent behavioral phenotypes in response to repeated cocaine treatment. Our studies further indicated that such developmental deletion of G9a selectively in Drd2 neurons resulted in the unsilencing of transcriptional programs normally specific to striatonigral neurons and in the acquisition of Drd1-associated projection and electrophysiological properties. This partial striatopallidal to striatonigral 'switching' phenotype in mice indicates a new role for G9a in contributing to neuronal subtype identity and suggests a critical function for cell type-specific histone methylation patterns in the regulation of behavioral responses to environmental stimuli. 
a r t I C l e S Chronic exposure to cocaine, or other substances of abuse, induces persistent changes in genome-wide transcriptional profiles in the brain's reward circuitry, resulting in long-lasting behavioral abnormalities that characterize drug addiction 1 . Recent evidence suggests that cocaine-induced alterations in gene expression are mediated, in part, by direct regulation of the chromatin-modifying machinery and associated transcription factor complexes [2] [3] [4] . Data now indicate a prominent role for cocaine-mediated reductions in expression and activity of G9a, a repressive HMT, and the euchromatic modification that it deposits, H3K9me2 (dimethylation of Lys9 of histone H3), in nucleus accumbens (NAc) in regulating transcriptional, structural and behavioral plasticity in response to repeated drug treatment [5] [6] [7] [8] . G9a was similarly repressed in post-mortem NAc of humans addicted to cocaine (unpaired t-test, effect of addiction: t 16 = 2.028, P ≤ 0.05; n = 9 per group) ( Supplementary Fig. 1 and Supplementary Table 1 ), indicating that G9a and histone methylation are relevant to human addiction. Little is known, however, about the cell type-specific activities of G9a in NAc in regulating physiological and behavioral responses to cocaine. Recently, through targeted deletions of G9a in either Drd1 or Drd2 medium spiny neurons (MSNs), Schaefer and colleagues demonstrated that this HMT alters behavioral responsiveness to several pharmacological stimuli in a cell type-specific manner 9 , suggesting distinct functions for G9a, and for associated histone methylation states, in the regulation of distinct neuronal phenotypes.
We aimed to better understand G9a's role in regulating cocaineinduced behaviors through segregated analyses of G9a function in Drd1 versus Drd2 MSNs using a combination of genetic, behavioral and electrophysiological approaches. We found that repeated cocaine exposure reduced G9a expression in both Drd1 and Drd2 cells; however, we observed opposing behavioral responses to cocaine treatment in animals with conditional G9a knockout (KO) or adult G9a overexpression in Drd1 versus Drd2 neurons. Genomic, anatomical and electrophysiological characterizations of G9a revealed a previously uncharacterized role for this enzyme, whereby developmental loss of G9a selectively in Drd2 MSNs resulted in a partial striatopallidal to striatonigral switchinglike phenotype, with G9a KO Drd2 cells partly resembling Drd1 cells. Although G9a is a well-known mediator of tissue-specific transcriptional programs 10 , our data implicate the enzyme as an important regulator of neuronal subtype identity in the adult CNS.
RESULTS

Cocaine reduces G9a expression in Drd1 and Drd2 MSNs
To assess G9a expression profiles selectively in Drd1 versus Drd2 MSNs following repeated cocaine administration, we used a cell type-specific translational profiling method, translating ribosome affinity purification (TRAP) 11, 12 , which allows affinity purification of EGFP-tagged polyribosomal complexes and their associated mRNAs from adult neurons under the control of either Drd1a or Drd2 promoters (Drd1-TRAP; G9a fl/fl or Drd2; G9a fl/fl ) (Fig. 1a) .
a r t I C l e S
In accordance with previous findings [5] [6] [7] , quantitative PCR (qPCR) analyses indicated that G9a expression was significantly reduced in the striatum following repeated cocaine. This reduction was predominantly observed in Drd2-expressing MSNs (two-way ANOVA, cell type × drug; drug: F 1,8 = 37.05, P < 0.001; post hoc Bonferroni t-test, effect of drug on Drd2 MSNs: t 8 = 6.955, P < 0.001; effect of cell type: t 8 = 4.856, P < 0.01; n = 3 mice per group), with a more modest reduction observed in Drd1 cells (unpaired t-test, effect of drug on Drd1 MSNs: t 4 = 2.818, P < 0.05; n = 3 mice per group) (Fig. 1b) . mRNA encoding G9a's principal binding partner, G9a-like protein (Glp), which has also previously been demonstrated to be downregulated by repeated cocaine treatment 6 , was found to be robustly repressed in Drd1 MSNs, with a nonsignificant trend toward downregulation observed in Drd2 cells (unpaired t-test, effect of drug on Drd1 MSNs: t 4 = 4.997, P < 0.01; effect of drug on Drd2 MSNs: t 4 = 1.926, P = 0.13; n = 3 mice per group) (Fig. 1b) . In accord with previous data 5, 7 , mRNA for the H3K9me3 HMT, Suv39h1, was not significantly regulated by repeated cocaine in either cell type in striatum (Fig. 1b) .
G9a oppositely regulates behaviors in D1 versus D2 MSNs
Because cocaine-mediated reductions in G9a expression in NAc have previously been demonstrated to increase cocaine reward 5 , we next generated selective Drd1 and Drd2 G9a KO mice (Drd1-cre; Drd1-TRAP; G9a fl/fl or Drd2-cre; Drd2-TRAP; G9a fl/fl ) for direct examination of cell type-specific contributions of G9a to cocaine-mediated behaviors. G9a expression was significantly reduced following Cremediated recombination selectively in Drd1 or Drd2 cells (two-way ANOVA, cell type × genotype; genotype: F 1,9 = 103.6, P < 0.0001; post hoc Bonferroni t-test, effect of genotype in Drd1 MSNs: t 9 = 6.399, P < 0.001; Drd2 MSNs: t 9 = 7.951, P < 0.001; n = 3 or 4 mice per group) (Fig. 1c) , loss of which resulted in complete (100%) ablation of H3K9me2 in Cre-expressing striatal neurons (Fig. 1d) . Loss of G9a was associated with nonsignificant trends for reduced expression of Glp in both cell types, with no effect on Suv39h1 ( Supplementary  Fig. 2 ). Further work is needed to understand what controls the coordinated expression of G9a and Glp and how the balance between them influences neural gene expression. (e,f) Such conditional KO of G9a in Drd1 versus Drd2 MSNs resulted in distinct effects on both cocaine reward (CPP; e) and the locomotor activating effects of repeated cocaine exposure (f). (g) Representative images (scale bar, 50 µm) demonstrating cell type-specific overexpression of G9a (Flag-tagged) in Drd2-cre mice. Both HSV-Stop fl/fl -mCherry and G9a viruses express GFP irrespective of Cre expression, yet nuclear G9a (Flag) expression was only observed in a subpopulation of these MSNs (white circles, Drd2-cre + cells). Red circles denote non-overlapping expression (Drd2-cre − cells). (h) Drd2-specific, but not Drd1-specific, G9a overexpression in adult NAc reduced cocaine CPP. Data are presented as means ± s.e.m. * , # P ≤ 0.05, ** , ## P < 0.01, ***P < 0.001, ****P < 0. MSNs. As in previous findings 11 , we identified a limited set of genes in both cell types that displayed distinct regulation by repeated cocaine (Drd1, 253 genes; Drd2, 239 genes). The effects of G9a KO, however, within these two cell types, in both the presence and absence of cocaine, were much more pronounced, with many of these genes exhibiting distinct patterns of transcriptional unsilencing between Drd1 and Drd2 MSNs. Most of these genes that were de-repressed did not overlap with genes displaying endogenous regulation by repeated cocaine in wild-type animals, likely indicating an indirect link between the effects of developmental G9a KO and adult cocaine exposure on the behavioral phenotypes in Figure 1e ,f.
Further analysis of gene expression profiles following G9a KO identified a distinct pattern of transcriptional de-repression in Drd2 neurons, whereby expression of Drd1a was upregulated, with concomitant reductions in Drd2 expression and enhanced expression of many genes previously identified as Drd1 enriched (two-way ANOVA, drug × genotype for both Drd1 and Drd2 MSNs independently, false discovery rate 0.15) (Fig. 2a) . Further bioinformatic analysis of genes displaying altered expression profiles between wild-type and G9a KO cells indicated highly relevant associations between previously identified Drd1-enriched and Drd1-associated cocaine-mediated pathways selectively in Drd2 neurons (for example, regulation of the actin cytoskeleton, MAP kinase signaling, etc.) (Fig. 2b) . Of particular interest was the identification of two genes previously demonstrated to be essential for the postnatal differentiation of striatonigral neurons, Ebf1 (early B-cell factor 1) and its binding partner Zfp521 (zinc finger protein 521) 13, 14 . Both genes, which are enriched in wild-type Drd1 MSNs, were significantly upregulated following G9a KO in Drd2 Conditional KO of G9a in Drd2 MSNs phenocopied increased cocaine reward (unpaired t-test, effect of KO on conditioned place preference (CPP): t 16 = 2.090, P ≤ 0.05; n = 9 mice per group) ( Fig. 1e ) and locomotor sensitization (unpaired t-test, effect of KO on locomotor sensitization: t 16 = 2.264, P < 0.05; n = 9 mice per group) (Fig. 1f ) previously observed with global (i.e., both Drd1 and Drd2) KO of G9a in NAc 5 . In contrast, conditional G9a KO in Drd1 MSNs had the opposite effect on cocaine CPP and sensitization (unpaired t-test, effect of KO on CPP: t 16 = 3.482, P < 0.01; n = 8-10 mice per group; effect on locomotor sensitization: t 16 = 2.211, P < 0.05; n = 9 mice per group) (Fig. 1e,f) , indicating functional differences for G9a between Drd1 and Drd2 neuronal subtypes. Lastly, to address the functional significance of G9a in adult MSNs, we generated conditional Stop fl/fl herpes simplex viral (HSV) vectors to overexpress G9a selectively in Drd1 or Drd2 MSNs in NAc (Fig. 1g) . Consistent with robust downregulation of G9a expression in Drd2 MSNs following repeated cocaine administration, as well as enhanced behavioral responses to the drug in Drd2 developmental KOs, overexpression of G9a selectively in Drd2 cells reduced cocaine CPP (unpaired t-test, effect of Drd2 overexpression: t 10 = 2.159, P ≤ 0.05, n = 5-7 mice per group) (Fig. 1h) , suggesting a prominent role for Drd2 G9a activity in regulating cocaine-mediated reward. Overexpression of G9a in Drd1 MSNs, by contrast, did not affect cocaine CPP (unpaired t-test, effect of Drd1 overexpression: t 11 = 1.294, P > 0.05, n = 6 or 7 mice per group), further indicating different functions for G9a in these two interrelated cell types.
D2 KO promotes transcriptional unsilencing of D1 genes
To better understand the contribution of G9a to the observed behavioral phenotypes, we next employed genome-wide analyses to monitor the impact of repeated cocaine, G9a KO, or cocaine plus G9a KO in Drd1 (Supplementary Table 2 ) versus Drd2 (Supplementary Table 3) npg a r t I C l e S neurons. We did not observe similar results for Drd1 cells lacking G9a. These data suggest that repression of G9a in Drd2 cells during development results in the unsilencing of a Drd1-like transcriptional program that influences an animal's behavioral responsiveness to subsequent cocaine exposure in adulthood.
Following independent validations of both cocaine's and G9a's effects on Drd1a (two-way ANOVA, cell type × drug; cell type: F 1,8 = 182.4, P < 0.0001; post hoc Bonferroni t-test, effect of cell type: t 8 = 10.67, P < 0.0001; unpaired t-test, effect of cocaine on Drd2 MSN: t 4 = 2.945, P < 0.05; unpaired t-test, effect of genotype on Drd2 MSNs: t 4 = 3.673, P < 0.05; n = 3 mice per group) ( Fig. 2c) and Drd2 (two-way ANOVA, cell type × drug; cell type: F 1,8 = 10.32, P ≤ 0.01; unpaired t-test, effect of cell type: t 4 = 2.875, P < 0.05, post hoc Bonferroni t-test, effect of drug: t 8 = 3.531, P < 0.05; two-way ANOVA, cell type × genotype; genotype: F 1,9 = 8.035, P < 0.05; post hoc Bonferroni t-test, effect of genotype: t 9 = 3.884, P < 0.01; n = 3 or 4 mice per group) (Fig. 2d) expression selectively in Drd2 neurons, we performed in situ hybridization to further examine Drd1a expression in Drd2 MSNs upon G9a KO. In accord with data obtained from our bacterial artificial chromosome TRAP (bacTRAP) arrays and subsequent qPCR analyses, G9a KO selectively in Drd2 MSNs increased the number of Penk + cells (a marker for Drd2 MSNs) that were also Drd1a + (Fig. 2e) .
Next, compiling bioinformatic analyses from our bacTRAP arrays and from two independent data sets (bac-TRAP 11 and fluorescenceactivated cell sorting (FACS) 13 ), we found that genes across these lists overlapped considerably. We statistically categorized genes as either Drd1 or Drd2 enriched (pairwise comparison between Drd1 and Drd2 control saline, P < 0.005) to investigate whether a subset of Drd1-enriched genes were indeed unsilenced by cocaine, G9a KO or both. Many genes were significantly enriched in either Drd1 (564 genes; for example, Drd1a, Eya1 and Pdyn) or Drd2 (921 genes; for example, Drd2, Penk and Adora2a) MSNs (Fig. 3a and Supplementary Tables 4 and 5) . We then identified a subset of these genes, which we validated as Drd2 enriched, that were downregulated in Drd2 MSNs by either repeated cocaine (6.0%), G9a KO (4.7%) or both (9.1%) (P < 0.005) (Fig. 3b and  Supplementary Tables 6-8 ), effects that we verified through independent qPCR analysis (unpaired t-test, effect of genotype: Hdac5, t 4 = 4.382, P < 0.05; Fgf11, t 4 = 4.019, P < 0.05; Esrra, t 4 = 2.607, P ≤ 0.05; Hook2, t 4 = 5.391, P < 0.01; Ddb2, t 4 = 3.062, P < 0.05; n = 3 mice per group) (Fig. 3c) . Consistent with the notion that Drd2 MSNs experience a partial shift in transcriptional identity in response to developmental KO of G9a, subsequent analyses also demonstrated that a significant proportion of genes identified as Drd1-enriched displayed significant upregulation in Drd2 cells in response to repeated cocaine (9.4%), G9a KO (18.1%) or both (20.9%) (P < 0.005) (Fig. 3d and Supplementary Tables 9-11), results that we then verified by qPCR (unpaired t-test, effect of genotype: Pdyn, t 8 = 2.711, P < 0.05; Camk1g, t 8 = 3.579, P < 0.01; Gabrb1, t 8 = 4.338, P < 0.01; Esrrg, t 7 = 2.669, P < 0.05; Prkca, t 7 = 2.503, P < 0.05; n = 4-6 mice per group) (Fig. 3e) .
D2 KO leads to a partial D2-to-D1 switching phenotype Given that conditional deletion of G9a enhances Drd1-specific gene expression profiles in Drd2 MSNs, we investigated whether G9a KO results in functional adaptations in anatomical projections or cellular physiology that may further explain the observed behavioral responses to cocaine. Drd2-cre (control) and Drd2-cre; G9a fl/fl (Drd2 G9a KO) mice were stereotaxically injected intra-striatally with adeno-associated virus (AAV)-DIO-EYFP vectors containing a doubly floxed inverted EYPF marker. With this system, EYFP is exclusively expressed in Cre + MSNs, allowing cell type-specific tagging for use in anatomical tracing and slice physiology. First, to determine whether early postnatal deletion of G9a selectively in Drd2 MSNs alters the neurons' projection profiles, wild-type and Drd2 G9a KO animals received successive intra-caudate putamen and intraNAc injections of AAV-DIO-EYFP, followed by projection labeling 1 month after infection. In wild-type animals, projection terminals were clearly identified in both the ventral pallidum and the globus pallidus externus, arising from the ventral and dorsal striatum, respectively. 
npg a r t I C l e S
In accord with previous literature, we observed no labeling beyond pallidal regions in wild-type Drd2-cre mice. In Drd2 G9a KO animals, however, we observed clear labeling of projection terminals in substantia nigra, a midbrain region traditionally known to receive directpathway projections from Drd1, but not Drd2, MSNs originating in the striatum (Fig. 3f) . These data suggest that conditional KO of G9a in Drd2 MSNs leads to aberrant transcriptional programs that might influence the appropriate establishment of striatal circuitry. Next, to investigate whether G9a KO-induced expression of Drd1a in Drd2 MSNs results in functional Drd1 activity, we incubated AAV-DIO-EYFP infected NAc slices (Fig. 4a) from wild-type and Drd2 G9a KO animals in the presence or absence of the Drd1 agonist dihydrexidine hydrochloride and measured potassium currents in voltage clamp mode. In accord with published reports 15 , application of the D1 agonist decreased K + currents at hyperpolarized potentials in wild-type Drd1 MSNs, with no evoked responses observed in control Drd2 MSNs (Fig. 4b) . In G9a KO Drd2 neurons, however, D1 activation significantly reduced K + currents, as in wild-type Drd1 MSNs (unpaired t-test, effect of D1 agonist at −130 mV: t 13 = 3.086, P < 0.01; at −120 mV: t 13 = 3.077, P < 0.01; at −110 mV: t 13 = 2.613, P < 0.05; n = 7 or 8 cells per group) (Fig. 4b,c) , demonstrating the presence of functional D1 receptors on G9a KO Drd2 neurons.
Recent work has established distinct roles for evoked excitability and postsynaptic responses between Drd1 and Drd2 MSNs in the npg a r t I C l e S regulation of cocaine-mediated behaviors 16, 17 18 , primarily in Drd1 cells [19] [20] [21] , in response to chronic cocaine exposure and has been shown to increase drug reward 20 ( Fig. 4d) . Increased ∆Fosb and other IEG expression in response to G9a KO exclusively in Drd2 MSNs further suggests a shift toward Drd1 transcriptional reprogramming and altered cellular physiology. Although observed increases in IEG expression in G9a KO Drd2 MSNs suggest increased activity, such changes are difficult to infer, since IEGs can be regulated by cellular signaling cascades in the absence of changes in neuronal firing. We thus directly investigated Drd1 and Drd2 MSN excitability in NAc after conditional G9a KO. We observed a dramatic enhancement in neuronal firing in response to current injections selectively in Drd2 neurons lacking G9a (unpaired t-test, effect of genotype in Drd2 MSNs, 50 pA: t 29 = 2.846, P < 0.01; 100 pA: t 28 = 2.655, P ≤ 0.01; n = 15 or 16 cells per group), with no effect seen in G9a KO Drd1 MSNs (Fig. 4e,f) . In accord with the increased excitability, Drd2 neurons lacking G9a also displayed a reduced threshold to induce the first spike (rheobase) in response to current injections (unpaired t-test, effect of genotype: t 25 = 2.608, P ≤ 0.01; n = 8-16 per group) (Fig. 4g) and increased membrane input resistance in the steady-state current-voltage (I-V) relationship (unpaired t-test, effect of genotype in Drd2 MSNs, −50 pA: t 22 = 2.180, P < 0.05; −25 pA: t 22 = 2.269, P < 0.05; 25 pA: t 22 = 2.842, P < 0.01; n = 8-16 per group) (Fig. 4h,i) .
DISCUSSION
Repeated cocaine exposure reduces G9a expression and activity in striatum, leading to persistent changes in gene expression, neuronal morphology and behavior 5 . Here we found that G9a expression was downregulated in both Drd1 and Drd2 MSNs; however, the functional impact of G9a ablation or overexpression on cocaine-induced behaviors segregated by neuronal subtype. Further investigations examining the consequences of developmental G9a KO in Drd1 versus Drd2 neurons demonstrated a previously uncharacterized role for G9a in influencing striatal neuron subtype specification. Selective G9a KO in Drd2 expressing neurons induced a partial phenotypic switch by downregulating certain striatopallidal and de-repressing certain striatonigral enriched genes and by altering the axonal projection profiles and functional D1 receptor responsiveness in Drd2 neurons. This partial Drd2-Drd1 switching phenotype is associated with enhanced sensitivity to the rewarding and locomotor activating effects of cocaine. Collectively, our results provide insight into the role of cell type-specific chromatin regulatory mechanisms in the development of behavioral plasticity in response to cocaine and reveal that G9a helps control neuronal subtype identity during development.
G9a has previously been shown to suppress neuronal genes in nonneuronal cells through repressive-complex associations with RE1 silencing transcription factor (REST) and Mediator, a multiprotein interface between RNA polymerase II and locus-specific transcription factors 22 . To our knowledge, however, a role for G9a in cell type specification within a given tissue has not yet been demonstrated. Here we provide direct evidence that G9a-mediated silencing, likely coupled to its euchromatic HMT activity, controls not only tissuespecific gene expression programs, but also the specification of closely related neuronal subtypes in the same tissue (for example, Drd1 versus Drd2 MSNs of striatum). Although Drd1 versus Drd2 MSNs have previously been shown to differentially express numerous genes, many of which contribute to these cells' identities and distinct functional outputs 11, 13 , the mechanisms controlling such distinct fates have remained unclear. The Drd2-to-Drd1 phenotypic switch mediated by G9a KO is obviously not complete: the changes observed here in transcriptional profiles and anatomical projections are partial. Moreover, while G9a KO in Drd2 MSNs increased their excitability, previous work has shown that Drd1 MSNs are less excitable than Drd2 MSNs 23 . Thus, G9a is likely to be only one of many chromatin regulatory proteins involved in establishing MSN cell type specificity. Nevertheless, it is becoming increasingly clear that alterations in G9a, both developmentally and in the adult CNS, contribute substantially to neuronal function. It also must be noted that G9a may control cell function through mechanisms other than its HMT activity 10 . Moving forward, it will be important to further dissect the molecular mechanisms of G9a action in the CNS during periods of neurodevelopment and in adult brain in response to environmental stimuli.
Our findings suggest a disassociation between G9a's roles during neurodevelopment in regard to mediating neuronal subtype specification and its function in adult brain as a modulator of stimulusinduced gene expression. Although both developmental KO of G9a and endogenous repression of G9a in adult brain following repeated cocaine result in altered behavioral responses to the drug, it appears that the underlying molecular mechanisms are distinct. For example, repeated exposure to cocaine has been shown to increase dendritic spine density of NAc MSNs [24] [25] [26] [27] ; this phenomenon is thought to contribute to an animal's increased behavioral responsiveness to cocaine and has been linked directly to suppression of G9a 5 . This response-both increased dendritic spine density and suppression of G9a 5 -is mediated by ∆FosB, which forms a negative feedback loop with G9a during chronic cocaine exposure. Of interest is the recent observation that ∆FosB persistently accumulates, and thereby promotes increased dendritic spine density, exclusively in Drd1 MSNs in response to repeated cocaine 19, 21, 28 , suggesting that Drd1-specific G9a repression in the adult is vital to the potentiation of cocaine-induced behaviors. That deletion of G9a from Drd1 MSNs during development results in an opposite behavioral phenotype is likely to reflect a developmental phenomenon.
Although G9a is also reduced in Drd2 MSNs in response to cocaine, the behavioral consequences of this effect in adult NAc are less clear. This is because the dramatic developmental abnormalities seen in Drd2 neurons upon loss of G9a make it difficult to infer anything about the function of this enzyme in the adult. By contrast, the dramatic suppression of G9a in adult Drd2 MSNs in response to chronic cocaine and the ability of G9a overexpression in Drd2 MSNs of adult animals to suppress cocaine reward nevertheless suggest that G9a also regulates npg a r t I C l e S cocaine action via this cell type. The developmental effects of G9a KO in Drd2 MSNs raise the question of whether similar abnormalities might be induced in adult neurons by cocaine. We believe that this is unlikely given the timeframe in which rodent studies have been conducted; however, it is difficult to truly gauge the impact of longterm repression of G9a by cocaine. For example, ~1 week of cocaine exposure downregulates G9a expression in striatum, an effect that persists for several days during withdrawal 5 , but this may not constitute enough time to permit deficits in neural cell type specification seen upon developmental deletion of the gene. Therefore, future studies involving cell type-specific KO of G9a in adult animals will be needed to further uncover distinct functions of the enzyme in Drd1 versus Drd2 MSNs in response to cocaine exposure.
Interestingly, chronic cocaine exposure has been shown to reduce the expression and functionality of Drd2 in striatum 29 , a phenomenon that is believed to contribute to increased drug reward and drug seeking behavior 30 . These findings have recently been supported by cell typespecific optogenetic dissections of Drd1 versus Drd2 MSNs in mouse NAc: Lobo et al. demonstrated that increasing the firing of Drd1 MSNs increases cocaine reward and locomotor sensitization, while activation of Drd2 MSNs exerts the opposite effects 16 . Our present data are in direct agreement with these previous studies, as we too observed cocaine-mediated alterations in dopamine receptor expression in striatum consistent with increased Drd1 tone: conditional G9a KO selectively from Drd2 neurons resulted in the unsilencing of Drd1-specific gene expression profiles and functional Drd1 activity in these cells, associated with increases in cellular excitability and behavioral responsiveness to cocaine, thus mimicking those effects seen via optogenetic stimulation of Drd1 MSNs.
In conclusion, our data demonstrate that G9a contributes to the specification of striatal MSN subtypes during development and that such actions have prominent effects on cocaine sensitivity. We also provide a genome-wide exploration of genes in Drd1 versus Drd2 MSNs that show abnormal regulation in response to repeated cocaine administration as a consequence of the cell type-specific loss of G9a during this developmental period. Although a master regulator of gene expression and euchromatic silencing, G9a also appears to be important in the CNS for guiding fundamental aspects of neuronal subtype identity, and therefore function, in adult brain. Gaining a broader understanding of the physiological and behavioral consequences of chromatin dysregulation during early neurodevelopment will aid in the development of therapeutics aimed at treating addiction and other devastating psychiatric disorders.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Gene Expression Omnibus, GSE54656. 
ONLINE METHODS
Animals.
Mice were housed at four to five per cage with a 12-h light/dark cycle (lights on from 0700 to 1900 h) at constant temperature (23 °C) with ad libitum access to food and water. All animal protocols were approved by the IACUCs at UT Southwestern Medical Center, Mount Sinai and The Rockefeller University. generation of transgenic mouse lines. Drd1-and Drd2-cre mice (EY262 and ER44, Gensat 31 ) and Drd1-and Drd2-TRAP mice 11 were bred to G9a fl/fl mice 32 to generate Drd1-cre; G9a fl/fl and Drd2-cre; G9a fl/fl mice for electrophysiological analysis, as well as Drd1-cre; Drd1-TRAP; G9a fl/fl , Drd1-TRAP; G9a fl/fl , Drd2-cre; Drd2-TRAP; G9a fl/fl and Drd2-TRAP; G9a fl/fl mice for cell type-specific ribosomeassociated RNA purification as previously described 9 . Drd2-cre; Drd2-eGFP; G9a fl/fl and Drd2-eGFP; G9a fl/fl used for immunofluorescence studies were generated as previously described 9 . All mice were backcrossed to the C57Bl/6 background for >5 generations, and genotyping was performed as previously described.
drugs. Cocaine HCl was obtained from Sigma-Aldrich and used at a concentration of 20 mg/kg i.p. Mice were immediately returned to their home cage after each injection, unless otherwise stated.
Quantifying protein expression from human post-mortem brain. Postmortem human brain tissue was obtained from the Quebec Suicide Brain Bank (IRB approval from Douglas Mental Health University Institute, Montreal, Quebec, Canada). Tissue preservation proceeded as described previously 33 . Once obtained, brains were placed on wet ice and transported to the Quebec Suicide Brain Bank facilities. Once dissected, tissues were flash frozen in 2-methylbutane at −40 °C. All frozen tissues were stored separately in plastic bags at −80 °C longterm. Specific brain regions were later sectioned from frozen coronal slices.
This cohort was composed of 1 female and 17 male subjects, ranging in age between 18 and 66 years. All subjects died suddenly without protracted medical illness or extended agonal states. For each case, the cause of death was determined by the Quebec Coroner Office, and toxicological screens were conducted to obtain information on medication and illicit substance use at the time of death. The subject group consisted of 9 individuals who met the Structured Clinical Interview for DSM-IV (Diagnostic and Statistical Manual of Mental Disorders-IV) Axis I Disorders: Clinician Version (SCID-I) criteria for cocaine dependence. The control group comprised 9 subjects with no history of cocaine dependence and no major comorbid psychiatric diagnoses. Groups were matched for subject age, post-mortem interval and pH. For all subjects, psychological autopsies were performed, giving us access to detailed information on psychiatric and medical histories, as well as other relevant sociodemographic and clinical data (Supplementary Table 1) .
To quantify G9a protein expression (Supplementary Fig. 1 ), frozen NAc tissue was homogenized in 30 µl of homogenization buffer (320 mM sucrose, 5 mM HEPES buffer, 1% SDS, phosphatase inhibitor cocktails I and II (Sigma) and protease inhibitors (Roche)) using an ultrasonic processor (Cole Parmer). Protein concentrations were determined using a DC protein assay (Bio-Rad), and 50 µg of protein was loaded onto 4-15% gradient Tris-HCl polyacrylamide gels for electrophoretic fractionation (Bio-Rad). Samples were next transferred to nitrocellulose membranes and blocked in Odyssey blocking buffer (Li-Cor). Blocked membranes were incubated overnight at 4 °C in primary antibody (1:500 G9a, Millipore 09-071) in Odyssey blocking buffer. After washing with TBST, membranes were incubated with IRDye secondary antibodies (1:5,000 to 1:10,000; Li-Cor) dissolved in Odyssey blocking buffer for 1 h at room temperature. Blots were then imaged with the Odyssey Infrared Imaging system (Li-Cor) and were quantified by densitometry using ImageJ (NIH). The amount of protein loaded into each lane was normalized to levels of glyceraldehyde 3-phosphate dehydrogenase (1:5,000, Millipore MAB374).
TRAP, qPcR and arrays. Polyribosome-associated mRNAs from 2-to 5-monthold, age-and sex-matched Drd1-cre; Drd1-TRAP; G9a fl/fl and Drd1-TRAP; G9a fl/fl mice and Drd2-cre; Drd2-TRAP; G9a fl/fl and Drd2-TRAP; G9a fl/fl mice (n = 2-4 mice per genotype per drug treatment, 2 h after the last of eight repeated cocaine injections of 20 mg/kg per day) were obtained as previously described 9, 11, 12 . EGFP-labeled ribosomes and associated mRNAs were immunoprecipitated using a mix of two monoclonal anti-GFP antibodies (50 µg of clones #19C8 and #19F7 for each immunoprecipitation, available at the Sloan-Kettering Monoclonal Antibody Facility). Purified mRNA was amplified and processed for microarray and qPCR analysis using the Affymetrix two-cycle cDNA synthesis kit as previously described 11, 12 . Affymetrix Mouse Genome 430 2.0 arrays were used in all experiments. Information regarding the array design and features can be found at http://www.affymetrix.com/estore/browse/products.jsp?productId=131477#1_1. Mouse Genome 430 2.0 arrays were scanned using the GeneChip Scanner 3000 (Affymetrix) and globally scaled to 150 using the Affymetrix GeneChip Operating Software (GCOS v1.4).
cDNA was quantified by qPCR with SYBR Green. Each reaction was run in duplicate and analyzed using the ∆∆C t method as previously described 34 . Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) was used as a normalization control and was not found to be altered by any manipulations described throughout the manuscript. See Supplementary Table 12 for mRNA primer sequences.
Behavior. Conditioned placed preference (CPP)
. CPP was tested as previously described 5 . Briefly, 8-to 12-week-old Drd1-TRAP; G9a fl/fl , Drd1-cre; Drd1-TRAP; G9a fl/fl , Drd2-TRAP and Drd2-cre; Drd2-TRAP; G9a fl/fl mice were placed into conditioning chambers consisting of three distinct environments. Mice displaying preference for either of the two conditioning chambers were excluded (<5% of all animals). Conditioning groups were subsequently balanced to adjust for chamber bias. On conditioning days (subsequent 4 d), animals were injected with either saline (days 1 and 3) or cocaine (10 mg/kg, i.p.) (days 2 and 4) and were then confined to one chamber in the afternoon for 30 min. On the test day, animals were placed back into the CPP apparatus without treatment for 20 min and evaluated for which side they preferred. Locomotor responses to cocaine were assessed by beam break analysis in the cocaine-paired chambers to ensure the effectiveness of drug treatment. For all groups, baseline locomotor responses to saline were assessed to ensure that locomotion was not affected by genotype (data not shown). For HSV CPP experiments (Fig. 1h) , an accelerated conditioning paradigm was employed. Briefly, 48 h after surgery, mice were injected with saline (day 1 morning, day 2 night) or cocaine (day 1 night, day 2 morning) during which they were confined to one chamber for 30 min as described. On day 3, CPP testing proceeded as stated previously. Behaviors were assessed during the animals' light cycles.
Locomotor activity. 8-to 12-week-old Drd1-TRAP; G9a fl/fl , Drd1-cre; Drd1-TRAP; G9a fl/fl , Drd2-TRAP; G9a fl/fl and Drd2-cre; Drd2-TRAP; G9a fl/fl mice were injected once daily for 14 d with cocaine (20 mg/kg, i.p.) and immediately returned to their home cages. One week later, animals were habituated in locomotor boxes for 60 min and then monitored for locomotor activity after a single saline injection (60 min) using the Photobeam Activity System (San Diego Instruments). In accordance with previous findings 9, 35 , all animals habituated normally and displayed similar responses to a saline injection. Next animals were injected with a low dosage of cocaine (5 mg/kg, i.p.) and monitored for locomotor activity for 30 min. All animals used in this study displayed enhancements in locomotor activity in response to cocaine above that of saline treated controls. Data are presented as a percentage control (mutant/control × 100) of total beam breaks over the course of the 30 min test comparing mutant mice to respective wild-type littermates. Locomotor behaviors were assessed during the animals' light cycle.
TRAP array analyses.
Affymetrix probe sets summary. Probe level intensity files (CEL) were imported into Affymetrix's Expression Console (v1.1) program for analysis. The RMA algorithm was used for normalization and probe level summarization files (CHP) were then exported for further analysis. Only 1 of 30 files was filtered out because it failed default quality thresholds. Two negative control files were also removed, leaving 27 files remaining across the three design factors.
Differential analysis. Two-way ANOVAs among different genotypes and experimental treatments were performed for each cell type individually to identify genes displaying differential expression. For each gene, three F-tests were performed for genotype, treatment and their interaction. All F-test results were subjected to multiple-testing corrections using the Benjamini-Hochberg procedure. FDR < 15% was used as a cutoff to select genes for the heat maps displayed in Figure 2 .
Pairwise comparisons were performed between two groups of any combination of the three factors using Student t-tests. A P value of <0.005 was used as a cutoff. This approach was first used to compare compiled data sets: (i) control-saline-Drd1
No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to those reported in previous publications from our laboratory. Furthermore, variance was found to be similar between groups being statistically compared. With the exception of qPCR and microarray analyses, all experiments were conducted with the experimenter blind to genotype. For all molecular, behavioral and electrophysiological experiments, animals were randomly assigned to groups (segregated by genotype). Furthermore, for all molecular experiments, tissue collected from treated animals was randomly pooled to provide ample tissue for biochemical procedures and to minimize variance across cohorts. Although normality was not formally tested for every experiment, observations of the data suggest that sample distributions do not deviate significantly from that of a normal distribution curve.
